Aquestive Therapeutics, Inc. (AQST)
收市後：
| 前收市價 | 3.9300 |
| 開市 | 3.9800 |
| 買盤 | 4.0600 x 1800 |
| 賣出價 | 4.0900 x 1800 |
| 今日波幅 | 3.9700 - 4.2497 |
| 52 週波幅 | 1.2510 - 6.2300 |
| 成交量 | |
| 平均成交量 | 2,561,371 |
| 市值 | 366.169M |
| Beta 值 (5 年，每月) | 2.91 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.1300 |
| 業績公佈日 | 2024年5月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 9.00 |
InvestorPlaceComing FDA Approvals Could Send These 3 Drug Stocks Soaring
In the biotech and pharmaceutical world, FDA approval is the number one needle mover for drug stocks. Why? Because FDA approval for a drug or treatment can bring years or even decades of steady, high-margin revenue. This is why investors who specifically look to target drug stocks are always aware of an upcoming FDA catalyst for that company. FDA approvals are bullish whether the company is a pre-revenue startup or a global pharmaceutical giant. At the same time, FDA rejections can tank a drug s
ZacksAquestive Therapeutics (AQST) Ascends While Market Falls: Some Facts to Note
Aquestive Therapeutics (AQST) concluded the recent trading session at $4.14, signifying a +0.24% move from its prior day's close.
ZacksAquestive Therapeutics (AQST) Flat As Market Sinks: What You Should Know
In the closing of the recent trading day, Aquestive Therapeutics (AQST) stood at $4.38, denoting no change from the preceding trading day.
